Bio Medica Laboratories Ltd (BMLL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Bio Medica Laboratories Ltd on NSE and BSE, with an AI summary of each filing.
Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 13 Nov 2026, 5:30 am
Bio Medica Laboratories Schedules Board Meeting on 13th Nov'26 for Half-Year Results Bio Medica Laboratories Limited has scheduled a meeting of its Board of Directors on 13th Nov'26. The board will inter-alia consider, evaluate, and approve the company's unaudited financial results for the half-year ended Sep'26.
BMLL : 13-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 05, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 13, 2026, To consider and approve the financial results for the period ended September 30, 2026
Intimation · 13 Nov 2026, 5:30 am
Bio Medica Laboratories Postpones Board Meeting to 13th Nov'26 for Half-Year Financial Results Bio Medica Laboratories Limited has postponed its Board of Directors meeting, originally scheduled for 5th Nov'26, to 13th Nov'26. The meeting has been rescheduled due to delays in finalizing the financial results. The board will convene to consider, approve, and take on record the company's standalone and consolidated financial results alongside the limited review report for the half-year ended 30th Sep'26.
Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
Bio Medica Laboratories Schedules Board Meeting on 5th Nov'26 for Half-Yearly Results Bio Medica Laboratories Limited has scheduled a meeting of its Board of Directors on 5th Nov'26. The board will inter-alia consider, evaluate, and approve the company's unaudited financial results for the half year ended Sep'26.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 05 Nov 2026, 5:30 am
Bio Medica Laboratories Board to Consider H1 FY27 Financial Results Bio Medica Laboratories Ltd. announced that its Board of Directors will meet on 5th Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the half year ended 30th Sep'26. Additionally, the company confirmed that the trading window for dealing in its securities has been closed for designated persons from 1st Oct'26 and will reopen 48 hours after the declaration of the financial results.
Non-Applicability of Corporate Governance Report for the 2nd Quarter Ended on 30th September, 2026.
Others (Uncategorized) · 26 Oct 2026, 8:44 pm
Bio Medica Laboratories Claims Exemption from Q2 Corporate Governance Reporting Bio Medica Laboratories Limited notified the NSE that the Corporate Governance Report under Regulation 27(2) of SEBI LODR Regulations, 2015 is not applicable for Q2 ended 30th Sep'26. The company claimed exemption under Regulation 15(2) due to its listing on the NSE SME platform and maintaining paid-up equity capital below ₹10 cr and net worth below ₹25 cr. The company confirmed it will comply with the relevant governance provisions within six months should the regulations become applicable.
SDD Certificate as per Regulation3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015
Others (Uncategorized) · 21 Oct 2026, 4:28 pm
Bio Medica Laboratories Submits SDD Compliance Certificate for Q2 FY27 Bio Medica Laboratories Limited submitted its Structured Digital Database (SDD) compliance certificate for the quarter ended 30th Sep'26, pursuant to Regulations 3(5) and 3(6) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Compliance Officer Khushi Gupta confirmed that an internal, non-tamperable SDD with audit trail capabilities for eight years is fully operational. The company successfully captured all five required Unpublished Price Sensitive Information (UPSI) events during the quarter, including specific details regarding access control, nature of UPSI, and timestamping.
Bio Medica Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 29 Sept 2026, 7:44 pm
Bio Medica Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026
Annual General Meeting · 28 Sept 2026, 11:33 pm
Bio Medica Laboratories Limited has informed the Exchange about General Updates
Annual General Meeting · 28 Sept 2026, 11:31 pm
Bio Medica Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026
Annual General Meeting · 04 Sept 2026, 10:34 pm
Bio Medica Laboratories Limited has informed the Exchange regarding 'Corporate Announcement/Information under Regulation 44 of SEBI (LODR)Regulations, 2015 regarding providing Remote E-Voting Facilities for the Annual GeneralMeeting to be held on 28th September, 2026.'.
Annual General Meeting · 03 Sept 2026, 12:18 am
Bio Medica Laboratories Announces E-Voting Details for 11th AGM Bio Medica Laboratories Ltd announced remote e-voting details for its 11th Annual General Meeting scheduled on 28th Sep'26. Facilitated by NSDL, the e-voting process establishes a cut-off date of 22nd Sep'26 for shareholder eligibility. The voting window opens on 25th Sep'26 and closes at 05:00 PM on 27th Sep'26. CS Vishakha Agrawal has been appointed as the scrutinizer to oversee the electronic voting process.
Bio Medica Laboratories Limited has informed the Exchange that Record date for the purpose of Meeting is 22-Sep-2026.
Others · 03 Sept 2026, 12:15 am
Bio Medica Laboratories Announces 11th AGM and Book Closure Dates Bio Medica Laboratories Ltd (BMLL) scheduled its 11th Annual General Meeting for 28th Sep'26 via video conferencing. To determine shareholder eligibility for the meeting, the company set the record date as 22nd Sep'26 and announced its annual book closure period from 23rd Sep'26 to 28th Sep'26.
Bio Medica Laboratories Limited has informed the Exchange regarding Appointment of Mrs Vishakha Agrawal as Other of the company w.e.f. September 02, 2026.
Change in Management · 03 Sept 2026, 12:14 am
Bio Medica Laboratories Appoints Vishakha Agrawal & Associates as Secretarial Auditor Bio Medica Laboratories Ltd appointed M/s. Vishakha Agrawal & Associates as Secretarial Auditor, effective 2nd Sep'26. Approved by the Board, the appointment spans a consecutive five-year term from FY26 through FY30, pending shareholder approval at the upcoming Annual General Meeting. The Indore-based firm specializes in company law, securities regulations, and secretarial audits. This corporate governance update complies with SEBI LODR Regulation 30 requirements, noting no relationships exist between the newly appointed secretarial auditor and current company directors.
Bio Medica Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026.
Outcome · 03 Sept 2026, 12:09 am
Bio Medica Laboratories Schedules 11th AGM and Appoints Secretarial Auditor Bio Medica Laboratories' board met on 2nd Sep'26 to approve its FY26 annual reports and schedule the 11th AGM for 28th Sep'26 via video conferencing. The book closure period is set from 23rd Sep'26 to 28th Sep'26, with a 22nd Sep'26 cut-off date for e-voting. Furthermore, the board appointed M/s. Vishakha Agrawal & Associates as Secretarial Auditor for a five-year term spanning FY26 to FY30, and designated the firm as the scrutinizer for the upcoming AGM's voting process.
Bio Medica Laboratories Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 27 Aug 2026, 11:22 pm
Bio Medica Labs Shareholders Approve Key Corporate Actions On 27 Aug'26, shareholders of Bio Medica Laboratories (BMLL) approved four resolutions via postal ballot. These include the disinvestment of its 51% stake in subsidiary Vitamax Private Limited and providing loans/guarantees under section 185 of the Companies Act, both via special resolution. Shareholders also approved increasing the investment threshold to ₹100 Crores under section 186 and authorizing related party transactions up to ₹50 Crores. All resolutions passed with 100% of votes in favour from promoter and public shareholders who participated.
Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 02-Sep-2026 to consider Other business.
Intimation · 26 Aug 2026, 9:52 pm
Bio Medica Laboratories Board Meeting Scheduled for Other Business Bio Medica Laboratories has announced a Board of Directors meeting scheduled for 02-Sep'26. The primary agenda item listed for consideration is "Other business." The unspecified nature of the agenda may warrant investor attention for any subsequent disclosures or material outcomes from the meeting.
To consider and approve the Notice of 11th Annual General Meeting and to authorize someone to issue the same to all the shareholders and other matters
Intimation · 26 Aug 2026, 9:51 pm
Bio Medica Laboratories Limited has informed the Exchange regarding Appointment of Ms. Khushi Gupta as Company Secretary & Compliance Officer of the company w.e.f. August 14, 2026.
Change in Management · 14 Aug 2026, 5:12 pm
Bio Medica Labs Appoints New Company Secretary & Compliance Officer Bio Medica Laboratories (BMLL) has appointed Ms. Khushi Gupta as Company Secretary, Compliance Officer, and Key Managerial Personnel, effective 14 Aug'26. The appointment fills a casual vacancy created by the resignation of the previous officer. Ms. Gupta is an Associate Member of the ICSI and has extensive experience in corporate law, secretarial compliances, and corporate governance. She holds no shares in the company and has no relationship with the existing directors. This appointment ensures continuity in key compliance and governance functions.
Bio Medica Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on August 14, 2026.
Outcome · 14 Aug 2026, 5:08 pm
Bio Medica Laboratories Appoints New Company Secretary After Resignation Bio Medica Laboratories announced a key management change following its board meeting on 14 Aug'26. The board accepted the resignation of Ms. Pratiksha Bhandari from the role of Company Secretary & Compliance Officer, effective from 13 Aug'26, due to personal reasons. Subsequently, Ms. Khushi Gupta, an Associate Member of the ICSI, has been appointed as the new Company Secretary & Compliance Officer, effective 14 Aug'26. Ms. Gupta has extensive experience in corporate law, governance, and secretarial compliance.
Bio Medica Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 13 Aug 2026, 7:13 pm
Bio Medica Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 13 Aug 2026, 7:06 pm
Bio Medica Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 13 Aug 2026, 7:05 pm
Bio Medica Laboratories Limited has informed the Exchange regarding Resignation of Ms Pratiksha Bhandari as Company Secretary & Compliance Officer of the company w.e.f. August 13, 2026.
Change in Management · 13 Aug 2026, 7:01 pm
BMLL Company Secretary and Compliance Officer Resigns Bio Medica Laboratories (BMLL) announced the resignation of Ms. Pratiksha Bhandari from her roles as Company Secretary, Compliance Officer, and Key Managerial Personnel. The resignation is effective from the close of business hours on 13 Aug'26. The company stated the reason for her departure is personal reasons and other professional commitments. This change in key management personnel is a notable governance event for the company, requiring the appointment of a successor to fulfill crucial compliance and secretarial functions.
Non-Applicability of Corporate Governance Report for the Quarter ended on 30th June, 2026.
Others (Uncategorized) · 29 Jul 2026, 7:55 pm
Bio Medica Labs Claims Exemption from Corporate Governance Reporting Bio Medica Laboratories (BMLL) informed the exchange on 29th Jul'26 that it is not required to submit a Corporate Governance Report for the quarter ended 30th Jun'26. The company claims exemption under Regulation 15(2) of SEBI (LODR) Regulations, 2015. This exemption applies as it is listed on the NSE SME Platform and meets the criteria of having paid-up capital not exceeding ₹10 crore and net worth not exceeding ₹25 crore. BMLL stated it will comply with the regulation within 6 months if applicability arises.
Bio Medica Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot
Annual General Meeting · 28 Jul 2026, 10:19 pm
Bio Medica Laboratories Seeks Shareholder Approval for Key Corporate Actions Bio Medica Laboratories is seeking shareholder approval via postal ballot for several key proposals. These include the disinvestment of its entire 51% stake in subsidiary Vitamax Private Limited, increasing the threshold for loans and investments up to ₹100 Crores, and authorizing Related Party Transactions up to ₹50 Crores. The e-voting period is scheduled from 29th Jul'26 to 27th Aug'26. The record date for determining eligible shareholders was 24th Jul'26. The proposals aim to provide operational and financial flexibility.